Olli Mikael Carpen

Person

Latest publications

  1. Potential Targets' Analysis Reveals Dual PI3K/mTOR Pathway Inhibition as a Promising Therapeutic Strategy for Uterine Leiomyosarcomas-an ENITEC Group Initiative

    Cuppens, T., Annibali, D., Coosemans, A., Trovik, J., ter Haar, N., Colas, E., Garcia-Jimenez, A., Van de Vijver, K., Kruitwagen, R. P. M., Brinkhuis, M., Zikan, M., Dundr, P., Huvila, J., Carpen, O., Haybaeck, J., Moinfar, F., Salvesen, H. B., Stukan, M., Mestdagh, C., Zweemer, R. P., Massuger, L. F., Mallmann, M. R., Wardelmann, E., Mints, M., Verbist, G., Thomas, D., Gomme, E., Hermans, E., Moerman, P., Bosse, T. & Amant, F. 1 Mar 2017 In : Clinical Cancer Research. 23, 5, p. 1274-1285 12 p.

    Publication: Contribution to journalA1 Refereed journal article

  2. Breast cancer in neurofibromatosis type 1: overrepresentation of unfavourable prognostic factors

    Uusitalo, E., Kallionpaa, R. A., Kurki, S., Rantanen, M., Pitkaniemi, J., Kronqvist, P., Harkonen, P., Huovinen, R., Carpen, O., Pöyhönen, M., Peltonen, S. & Peltonen, J. 17 Jan 2017 In : British Journal of Cancer. 116, 2, p. 211-217 7 p.

    Publication: Contribution to journalA1 Refereed journal article

  3. FHOD1 formin is upregulated in melanomas and modifies proliferation and tumor growth

    Peippo, M., Gardberg, M., Lamminen, T., Kaipio, K., Carpen, O. & Heuser, V. D. 1 Jan 2017 In : Experimental Cell Research. 350, 1, p. 267-278 12 p.

    Publication: Contribution to journalA1 Refereed journal article

View all (62) »

Education

Lääketieteen tohtori

ID: 116152